Synthesis of bi- And tricyclic α,β-unsaturated lactams as potential michael acceptors starting from heterocyclic imines

Synthesis

Volumn , Issue 4, 2009, Pages 665-673

  Schulz, Knut ^a   Watzke, Martin ^a   Johannes, Katharina ^a   Ullrich, Pasqual ^a   Martens, Jürgen ^a  

^a UNIVERSITY OF OLDENBURG   (Germany)

Author keywords

Heterocycles; Imines; Michael acceptor; Ring closing metathesis; Unsaturated lactams

Indexed keywords

HETEROCYCLES; IMINES; MICHAEL ACCEPTOR; RING-CLOSING METATHESIS; UNSATURATED LACTAMS;

CHLORINE COMPOUNDS; RUTHENIUM; SYNTHESIS (CHEMICAL);

AMIDES;

1,1,3,3 TETRAMETHYL 8,8A DIHYDRO 1H OXAZOLO[3,4 A]PYRIDIN 5 ONE; 1,1,3,3 TETRAMETHYL 8,8A DIHYDRO 1H THIAZOLO[3,4 A]PYRIDIN 5 ONE; 1,1,3,3,6 PENTAMETHYL 8,8A DIHYDRO 1H OXAZOLO[3,4 A]PYRIDIN 5 ONE; 1,1,3,3,6 PENTAMETHYL 8,8A DIHYDRO 1H THIAZOLO[3,4 A]PYRIDIN 5 ONE; 10,10 DIMETHYL 10,10A DIHYDRO 1H 9 OXA 4A AZAPHENANTHREN 4 ONE; 10,10 DIMETHYL 10,10A DIHYDRO 1H 9 THIA 4A AZAPHENANTHREN 4 ONE; 3,10,10 TRIMETHYL 10,10A DIHYDRO 1H 9 OXA 4A AZAPHENANTHREN 4 ONE; 3,10,10 TRIMETHYL 10,10A DIHYDRO 1H 9 THIA 4A AZAPHENANTHREN 4 ONE; CHLORIDE; IMINE; LACTAM DERIVATIVE; RUTHENIUM; UNCLASSIFIED DRUG;

ARTICLE; CHEMICAL REACTION; DRUG SYNTHESIS; HOSOMI SAKURAI REACTION; RING CLOSING METATHESIS;

EID: 63849210737     PISSN: 00397881     EISSN: 1437210X     Source Type: Journal    
DOI: 10.1055/s-0028-1083342     Document Type: Article

References (47)

1. (a) Navickiene, H. M. D.; Alecio, A. C.; Kato, M. J.; Bolzani, V. D.; Young, M. C. M.; Cavalheiro, A. J.; Furlan, M. Phytochemistry 2000, 55, 621.
2. (b) Chen, J. J.; Chang, Y. L.; Teng, C. M.; Su, C. C.; Chen, I. S. Planta Med. 2002, 68, 790.
3. (c) Chen, J. J.; Duh, C. Y.; Huang, H. Y.; Chen, I. S. Helv. Chim. Acta 2003, 86, 2058.
4. (d) Tsai, I. L.; Lee, F. P.; Wu, C. C.; Duh, C. Y.; Ishikawa, T.; Chen, J. J.; Chen, Y. C.; Seki, H.; Chen, I. S. Planta Med. 2005, 71, 535.
5. (e) Cardona, W.; Quinones, W.; Robledo, S.; Velez, I. D.; Murga, J.; Garcia-Fortanet, J.; Carda, M.; Cardona, D.; Echeverri, F. Tetrahedron 2006, 62, 4086.
6. (f) Ding, P. L.; Liao, Z. X.; Huang, H.; Zhou, P.; Chen, D. F. Bioorg. Med. Chem. Lett. 2006, 16, 1231.
7. (a) Sundberg, R. J.; Bukowick, P. A.; Holcombe, F. O. J. Org. Chem. 1967, 32, 2938.
8. (b) Hua, D. H.; Zhang, F.; Chen, J. J. Org. Chem. 1994, 59, 5084.
9. (c) Amat, M.; Perez, M.; Llor, N.; Bosch, J. Org. Lett. 2002, 4, 2787.
10. (d) Chandra, K. L.; Chandrasekhar, M.; Singh, V. K. J. Org. Chem. 2002, 67, 4630.
11. (e) Fuwa, H.; Kaneko, A.; Sugimoto, Y.; Tomita, T.; Iwatsubo, T.; Saski, M. Heterocycles 2006, 70, 101.
12. (f) Maio, D. G.; Tardella, P. A. Gazz. Chim. Ital. 1964, 94, 590.
13. (a) Flemming, A. Br. J. Exp. Pathol. 1929, 10, 226.
14. (b) Penicilline (C), In Römpp Online V. 3.1; Thieme: Stuttgart, 2008, RD-16-00773.
15. (c) Dalhoff, A. Infection 1979, 7, 294.
16. (d) Holzgrabe, U. Pharm. Unserer Zeit 2006, 35, 410.
17. (a) Gillies, P. S.; Dunn, C. J. Drugs 2000, 60, 333.
18. (b) Lohray, B. B.; Bhusan, V.; Rao, B. P.; Medhavan, G. R.; Murali, N.; Rao, K. N.; Reddy, A. K.; Rajesh, B. M.; Reddy, P. G.; Chakrabarti, R.; Vikramadithyan, R. K.; Rajagopalan, R.; Mamidi, R. N. V. S.; Jajoo, H. K.; Subramanian, S. J. Med. Chem. 1998, 41, 1619.
19. Elander, R. P. Appl. Microbiol. Biotech. 2003, 61, 385.
20. (a) Matsumoto, Y.; Tsuzuki, R.; Matsuhisa, A.; Takayama, K.; Yoden, T.; Uchida, W.; Asano, M.; Fujita, S.; Yanagisawa, I.; Fujikura, T. Chem. Pharm. Bull. 1996, 44, 103.
21. (b) Kobayashi, T.; Strobeck, M.; Schwartz, A.; Mori, Y. Eur. J. Pharmacol. 1997, 332, 313.
22. (c) Matsumoto, Y.; Tsuzuki, R.; Matsuhisa, A.; Yoden, T.; Yamagiwa, Y.; Yanagisawa, I.; Shibanuma, T.; Nohira, H. Bioorg. Med. Chem. 2000, 8, 393.
23. (d) Okuyama, K.; Kiuchi, S.; Okamoto, M.; Narita, H.; Kudo, Y. Eur. J. Pharmacol. 2000, 398, 209.
24. (e) Cecchetti, V.; Calderone, V.; Tabarrini, O.; Sabatini, S.; Filipponi, E.; Testai, L.; Spogli, R.; Martinotti, E.; Fravolini, A. J. Med. Chem. 2003, 46, 3670.
25. (a) Trapani, G.; Reho, A.; Morlacchi, F.; Latrofa, A.; Marchini, P.; Venturi, F.; Cantalamessa, F. Farmaco, Ed. Sci. 1985, 40, 369.
26. (b) Armenise, D.; Trapani, G.; Stasi, F.; Morlacchi, F. Arch. Pharm. (Weinheim, Ger.) 1998, 331, 54.
27. (a) Hayakawa, I.; Atarashi, S.; Yokohama, S.; Imamura, M.; Sakano, K.; Furukawa, M. Antimicrob. Agents Chemother. 1986, 29, 163.
28. (b) Atarashi, S.; Tsurumi, H.; Fujiwara, T.; Hayakawa, I. J. Heterocycl. Chem. 1991, 28, 329.
29. (c) Hirata, T.; Saito, H.; Tomioka, H.; Sato, K.; Jidoi, J.; Hosoe, K.; Hidaka, T. Antimicrob. Agents Chemother. 1995, 39, 2295.
30. Martens, J.; Offermanns, H.; Scherberich, P. Angew. Chem., Int. Ed. Engl. 1981, 20, 668; Angew. Chem. 1981, 93, 680.
31. Weber, M.; Jakob, J.; Martens, J. Liebigs Ann. Chem. 1992, 1.
32. Gröger, H.; Martens, J. Sulf. Lett. 1996, 19, 197.
33. Watzke, M.; Schulz, K.; Johannes, K.; Ullrich, P.; Martens, J. Eur. J. Org. Chem. 2008, 3859.
34. Böhme, H.; Hartke, K. Chem. Ber. 1963, 96, 600.
35. Schwarze, W.; Drauz, K.; Martens, J. Chem.-Ztg. 1987, 111, 149.
36. Hosomi, A.; Sakurai, H. Tetrahedron Lett. 1976, 1295.
37. (a) Hart, D. J.; Tsai, Y.-M. Tetrahedron Lett. 1981, 22, 1567.
38. (b) Kraus, G. A.; Neuenschwander, K. J. Chem. Soc., Chem. Commun. 1982, 134.
39. (c) Kano, S.; Yuasa, Y.; Shibuya, S. Heterocycles 1987, 26, 373.
40. (d) Herborn, C.; Zietlow, A.; Steckhan, E. Angew. Chem., Int. Ed. Engl. 1989, 28, 1399; Angew. Chem. 1989, 101, 1392.
41. (a) Rodriguez, S.; Castillo, E.; Carda, M.; Marco, J. A. Tetrahedron 2002, 58, 1185.
42. (b) Chen, Y.; Zhang, H.; Nan, F. J. Comb. Chem. 2004, 6, 684.
43. (c) Deiters, A.; Pettersson, M.; Martin, S. F. J. Org. Chem. 2006, 71, 6547.
44. (d) Liu, G.; Tai, W.-Y.; Li, Y.-L.; Nan, F.-J. Tetrahedron Lett. 2006, 47, 3295.
45. (e) Fiorelli, C.; Savoia, D. J. Org. Chem. 2007, 72, 6022.
46. 12
47. CCDC 706274 contains the supplementary crystallographic data for this paper. These data can be obtained free of charge from The Cambridge Crystallographic Data Centre via www.ccdc.cam.ac.uk/data-request/cif.